Clinical Trial Update: Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 [NA]

View source ↗

Summary

A clinical trial evaluating RINCE for reducing fibromyalgia effects (NCT02211508) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• RINCE

Snippet

Sponsor: Cerephex Corporation | Conditions: Fibromyalgia | NA | Status: TERMINATED